Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Actinium Pharmaceuticals, Inc. (ATNM)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  1.01.10.00.00.00.00.00.0
            Revenue growth  -10.0%       
Cost of goods sold  -37.8-28.00.00.00.00.00.00.0
Gross profit  38.929.20.00.00.00.00.00.0
            Gross margin  3774.3%2548.1%      
Selling, general and administrative   [+]12.08.16.35.56.79.29.011.3
Research and development  23.118.016.116.617.117.717.813.5
Other operating expenses  35.126.1      
EBITDA   [+]-30.7-22.5-21.9-21.7-23.8-26.9-26.8-24.8
            EBITDA margin  -2980.0%-1970.5%      
Depreciation and amortization  0.70.50.40.40.10.10.10.1
EBIT   [+]-31.4-23.1-22.4-22.1-23.8-26.9-26.8-24.8
            EBIT margin  -3047.9%-2016.3%      
Non-recurring items  2.71.9      
Interest income, net   [+]1.10.20.20.20.20.00.00.0
Other income (expense), net   [+]     0.32.53.8
Pre-tax income  -33.0-24.8-22.2-21.9-23.7-26.6-24.3-21.0
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -33.0-24.8-22.2-21.9-23.7-26.6-24.3-21.0
            Net margin  -3205.5%-2165.6%      
   
Basic EPS   [+]($1.37)($1.20)($1.83)($4.40)($0.22)($0.40)($0.50)($0.55)
Diluted EPS   [+]($1.37)($1.20)($1.83)($4.40)($0.22)($0.40)($0.50)($0.55)
   
Shares outstanding (basic)   [+]24.120.612.15.0106.066.748.538.2
Shares outstanding (diluted)   [+]24.120.612.15.0106.066.748.538.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy